Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11755337rdf:typepubmed:Citationlld:pubmed
pubmed-article:11755337lifeskim:mentionsumls-concept:C1265292lld:lifeskim
pubmed-article:11755337lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:11755337lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:11755337lifeskim:mentionsumls-concept:C1121052lld:lifeskim
pubmed-article:11755337lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:11755337pubmed:issue2lld:pubmed
pubmed-article:11755337pubmed:dateCreated2001-12-28lld:pubmed
pubmed-article:11755337pubmed:abstractTextNovel antibacterials agents, 2-(1H-indol-3-yl)tetrahydroquinolines, were prepared using hetero Diels-Alder chemistry and found to be effective in vitro against methicillin-resistant Staphylococcus aureus (MRSA). A structure-activity relationship (SAR) study was conducted to determine the important features of this series and to increase the potency of these compounds. Compounds were prepared that had minimum inhibitory concentrations (MIC's) < 1.0 microg/mL against MRSA, but had no activity versus vancomycin-resistant Enterococcus (VRE).lld:pubmed
pubmed-article:11755337pubmed:languageenglld:pubmed
pubmed-article:11755337pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755337pubmed:citationSubsetIMlld:pubmed
pubmed-article:11755337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755337pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11755337pubmed:statusMEDLINElld:pubmed
pubmed-article:11755337pubmed:monthJanlld:pubmed
pubmed-article:11755337pubmed:issn0960-894Xlld:pubmed
pubmed-article:11755337pubmed:authorpubmed-author:HoemannMichae...lld:pubmed
pubmed-article:11755337pubmed:authorpubmed-author:XieRoger LRLlld:pubmed
pubmed-article:11755337pubmed:authorpubmed-author:RossiRichard...lld:pubmed
pubmed-article:11755337pubmed:authorpubmed-author:MeyerSylviaSlld:pubmed
pubmed-article:11755337pubmed:authorpubmed-author:SidhuAlbanAlld:pubmed
pubmed-article:11755337pubmed:authorpubmed-author:CunyGregory...lld:pubmed
pubmed-article:11755337pubmed:authorpubmed-author:HauskeJames...lld:pubmed
pubmed-article:11755337pubmed:issnTypePrintlld:pubmed
pubmed-article:11755337pubmed:day21lld:pubmed
pubmed-article:11755337pubmed:volume12lld:pubmed
pubmed-article:11755337pubmed:ownerNLMlld:pubmed
pubmed-article:11755337pubmed:authorsCompleteYlld:pubmed
pubmed-article:11755337pubmed:pagination129-32lld:pubmed
pubmed-article:11755337pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11755337pubmed:meshHeadingpubmed-meshheading:11755337...lld:pubmed
pubmed-article:11755337pubmed:meshHeadingpubmed-meshheading:11755337...lld:pubmed
pubmed-article:11755337pubmed:meshHeadingpubmed-meshheading:11755337...lld:pubmed
pubmed-article:11755337pubmed:meshHeadingpubmed-meshheading:11755337...lld:pubmed
pubmed-article:11755337pubmed:meshHeadingpubmed-meshheading:11755337...lld:pubmed
pubmed-article:11755337pubmed:meshHeadingpubmed-meshheading:11755337...lld:pubmed
pubmed-article:11755337pubmed:meshHeadingpubmed-meshheading:11755337...lld:pubmed
pubmed-article:11755337pubmed:year2002lld:pubmed
pubmed-article:11755337pubmed:articleTitlePotent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives.lld:pubmed
pubmed-article:11755337pubmed:affiliationSepracor Inc., 111 Locke Dr., Marlborough, MA 01752, USA. mhoemann@sepracor.comlld:pubmed
pubmed-article:11755337pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11755337pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:11755337lld:chembl